Clinical Trial Update: Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating capecitabine as maintenance therapy versus observation in early-stage triple-negative breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Beni-Suef University | Conditions: Triple -Negative Breast Cancer | Phase 2 | Status: COMPLETED